Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995408 · ClinicalTrials.gov registry record · NA
Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT02995408: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02995408 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02995408, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
This study has three aims: Phase I: Through focus group interviews with expert clinicians, leaders of organizations, and parents with children with ASD, this study aims to identify the psychosocial needs of parents of children with ASD, specifically a) the types of concerns that parents find most difficult and stressful b) areas of concern that lack support and resources, and c) areas of need for education and skill training. This study also aims to gather feedback on the Benson-Henry Institute's Relaxation Response Resiliency Program (3RP). Phase II: Informed by Phase I findings, this study aims to develop and determine the feasibility and acceptability of a virtual 8-session Relaxation Response Resiliency (3RP) program for parents of children with ASD. Phase II: This study also aims to test the effectiveness of a pilot wait-list control trial, establishing efficacy of a virtual resiliency program.
Interventions
- BEHAVIORAL Relaxation Response Resiliency Program for Parents of Children with ASD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02995408
The ClinicalTrials.gov registry entry for NCT02995408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation Response Resiliency Program for Parents of Children with ASD is the first listed.
NCT02995408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02995408 about?
NCT02995408 is a clinical study titled "Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder". This study has three aims: Phase I: Through focus group interviews with expert clinicians, leaders of organizations, and parents with children with ASD, this study aims to identify the psychosocial needs of parents of children with ASD, specifically a) the types of concerns that parents find most d...
What is the current status of trial NCT02995408?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2016-12. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02995408?
The interventions under investigation include: Relaxation Response Resiliency Program for Parents of Children with ASD (BEHAVIORAL).
Who is sponsoring clinical trial NCT02995408?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.